top of page
.png)
Search
New Sjogren’s Treatments: Who Will Benefit?
On January 30, the Sjogren's Foundation's 2026 State of Sjogren’s CME Conference featured six new drugs currently in clinical trials. I share highlights from the conference and discuss how clinical studies might impact Sjogren’s care going forward.
Sarah Schafer, MD
Feb 35 min read
Sjogren's and Inflammation - Part I
Sjogren's is a systemic inflammatory disease, even if CRP and ESR are normal. Learn how cytokines may impact fatigue.
Sarah Schafer, MD
Dec 16, 20234 min read
Sjogren's Advocate pages are not handouts
Learn how to choose handouts that work well for clinician education, and why you can trust the information on Sjogren's Advocate.
Sarah Schafer, MD
Nov 18, 20212 min read
SSA, Autoimmunity, and Sjogren's
Sjogren's is called autoimmune, but it is not that simple. It is a complex, systemic immune-mediated disease.
Sarah Schafer, MD
May 16, 20215 min read
bottom of page